Topical Roflumilast Approved for Psoriasis Down to Age 2



Safety and efficacy data in younger children were consistent with data in adolescent and adult studies.
Medscape Medical News



Source link : https://www.medscape.com/viewarticle/topical-roflumilast-approval-expanded-include-children-ages-2026a1000m63?src=rss

Author :

Publish date : 2026-06-30 09:48:00

Copyright for syndicated content belongs to the linked Source.
Exit mobile version